Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared a post on X:
“Our review on “platinum chemotherapy for metastatic castration-resistant prostate cancer” has been published in Cancer Treatment.
Reviews at ESMO and Yüksel Ürün.
Platinum-based chemotherapy (esp. carboplatin) may be offered after first line treatments, if
-dDDR (esp. BRCA).
-Fit for chemotherapy.
-PARPi not available.”
Source: Erman Akkus/X